Tertiles of serum GGT | P trend | |||
---|---|---|---|---|
Men | Tertile 1 (0 ~ 22 U/L) | Tertile 2 (23 ~ 34 U/L) | Tertile 3 (35 ~ 73 U/L) | |
Case/participants | 184/822 | 240/800 | 315/802 | |
Prevalence, % | 19.5% | 28.0% | 39.4% | |
Odds ratio (95% CI) | ||||
Model 1 | reference | 1.6(1.2-2.2) | 2.8(2.1-3.8) | <0.001 |
Model 2 | reference | 1.4(1.0-1.9) | 2.3(1.7-3.1) | <0.001 |
Women | Tertile 1 (0 ~ 14 U/L) | Tertile 2 (15 ~ 19 U/L) | Tertile 3 (20 ~ 48 U/L) | |
Case/participants | 151/1273 | 226/1101 | 381/1278 | |
Prevalence, % | 10.9% | 19.7% | 28.8% | |
Odds ratio (95% CI) | ||||
Model 1 | reference | 1.9(1.4-2.5) | 3.1(2.4-4.0) | <0.001 |
Model 2 | reference | 1.8(1.3-2.3) | 2.5(1.9-3.3) | <0.001 |
Categories of BMI | ||||
<23 kg/m 2 | 23-25 kg/m 2 | >25 kg/m 2 | ||
Men | ||||
Case/participants | 215/977 | 217/655 | 307/792 | |
Prevalence, % | 18.8% | 32.5% | 38.4% | |
Odds ratio (95% CI) | ||||
Model 1 | reference | 2.0(1.6-2.6) | 2.7(2.2-3.4) | <0.001 |
Model 2 | reference | 1.9(1.5-2.4) | 2.3(1.8-2.9) | <0.001 |
Women | ||||
Case/participants | 211/1570 | 194/938 | 353/1144 | |
Prevalence, % | 12.4% | 20.6% | 29.3% | |
Odds ratio (95% CI) | ||||
Model 1 | reference | 1.7(1.3-2.3) | 2.8(2.2-3.6) | <0.001 |
Model 2 | reference | 1.6(1.2-2.1) | 2.4(1.8-3.1) | <0.001 |